SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BARD1 LIFE SCIENCES LIMITED(BD1)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
BARD1 LIFE SCIENCES LIMITED14/06/2016
EUROGOLD LIMITED28/05/200214/06/2016
ESMERALDA EXPLORATION LIMITED28/05/2002

Shareholder links

Our website ranking of BD1: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Level 11, 172 St Georges Terrace, Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000BD12
Address: Unit 202, Level 2 39 Mends Street South Perth WA 6151
Tel:  +61 8 9381 9550 Fax: +61 8 9388 7559

Date first listed: 18/04/1991
Company Secretary: Mrs Pauline Collinson
Sector: Health Care Equipment & Services Industry Group: XMJ
Activities: Developing and commercialising a blood test for lung cancer detection.

News & Events

Expand this box to read and print

we understand that on or about this date the company consolidated its shares 1 for 30

27/11/2020

The suspension of trading in the securities of Bard1 Life Sciences Limited will be lifted immediately, following receipt of a response to an ASX Query.

18/05/2018

The company issues a response to ASX Price Query.

18/05/2018

The company signed an assay development agreement with Thermo Fisher Scientific for Multiplex Research-Use-Only custom assay development. A RUO BARD1 autoantibody assay will be developed using ProcartaPlex Technology for performance on Luminex instrumentation. The first application of the ProcartaPlex Technology is to the BARD1-Ovarian test in development for detection of ovarian cancer.

18/05/2018

The securities of Bard1 Life Sciences Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a development contract.

14/05/2018

The securities of BARD1 Life Sciences Limited (previously Eurogold Limited) (the "Company") will be reinstated to official quotation from the commencement of trading on 20 June 2016, following the Company's compliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. 322,493,350 fully paid ordinary shares

17/06/2016

name changed from Eurogold Limited

14/06/2016
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    04/12/2020Geoffrey Cumming9,333$0.757$7,066
    02/12/2020Philip Powell70,000$0.697$48,762
    02/12/2020Max Johnston30,000$0.680$20,385
    22/11/2019Irmgard Irminger-Finger347,663$0.034$11,729
    29/11/2018Irmgard Irminger-Finger-8,599,683$0.024$204,982

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Geoffrey CummingNon Exec Chairman28/07/2020
    Leearne HinchCEO07/11/2016
    David A. TaylorJoint Managing Director 28/09/2001
    Allan CrippsNon Exec Director25/01/2020
    Max JohnstonDirector18/06/2019
    Philip PowellDirector18/06/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Irmgard Irminger-FingerDirector10/06/201615/01/2021
    Helen FisherNon Exec Director28/07/202025/11/2020
    Peter GunzburgExecutive Chairman, CEO24/09/200128/07/2020
    Brett MontgomeryNon Exec Director15/08/198918/06/2019
    Geoffrey LaurentDirector10/06/201612/08/2018
    Pauline CollinsonNon Exec Director18/11/201410/06/2016
    Lyle ProcterNon Exec Director29/11/201218/11/2014
    Arthur DewNon Exec Director23/10/201218/11/2014
    Mark WongAlternate Director07/12/201217/11/2014
    Neil MacLachlanNon Exec Director13/07/200423/10/2012
    Dennis FranksNon Exec Director24/09/200122/12/2006
    Christopher BarkerNon Exec Director28/07/2006
    Maxwell MontgomeryAlternate Director07/11/2001
    David SemmensAlternate Director05/10/2001

    Date of first appointment, title may have changed.